Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001

D. Brown, Paul; Gondi, Vinai; Pugh, Stephanie; A. Tome, Wolfgang; S. Wefel, Jeffrey; S. Armstrong, Terri; A. Bovi, Joseph; Robinson, Cliff; Konski, Andre; Khuntia, Deepak; Grosshans, David; L. S. Benzinger, Tammie; Bruner, Deborah; R. Gilbert, Mark; Roberge, David; Kundapur, Vijayananda; Devisetty, Kiran; Shah, Sunjay; Usuki, Kenneth; Marie Anderson, Bethany; Stea, Baldassarre; Yoon, Harold; Li, Jing; N. Laack, Nadia; J. Kruser, Tim; J. Chmura, Steven; Shi, Wenyin; Deshmukh, Snehal; P. Mehta, Minesh; A. Kachnic, Lisa; NRG Oncology, for

doi:10.1200/jco.19.02767

Public

Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001

Shared by NobleBlocks on Apr 1, 2020 • 12:00 AM UTC

Authors:

Paul D. Brown

Vinai Gondi

Stephanie Pugh

Abstract

PURPOSE Radiation dose to the neuroregenerative zone of the hippocampus has been found to be associated with cognitive toxicity. Hippocampal avoidance (HA) using intensity-modulated radiotherapy during whole-brain radiotherapy (WBRT) is hypothesized to preserve cognition. METHODS This phase III tria...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!